Neuronal injury regulates fractalkine: Relevance for HIV-1 associated dementia

Journal of Neuroimmunology

Volumn 138, Issue 1-2, 2003, Pages 144-155

  Erichsen, David ^a,b   Lopez, Alicia L ^a,b   Peng, Hui ^a,b   Niemann, Douglas ^a,b   Williams, Clancy ^a,b   Bauer, Michael ^a,b   Morgello, Susan ^c   Cotter, Robin L ^a,b   Ryan, Lisa A ^a,b   Ghorpade, Anuja ^b   Gendelman, Howard E ^b   Zheng, Jialin ^a,b,d  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c MOUNT SINAI MEDICAL CENTER   (United States)

^d NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Chemokines; Fractalkine; HIV 1 associated dementia; Inflammation; Macrophage

Indexed keywords

FRACTALKINE;

ADULT; APOPTOSIS; ARTICLE; ASTROCYTE; CELL TYPE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; FEMALE; FETUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LABORATORY TEST; MALE; NERVE CELL LESION; PATHOGENESIS; PRIORITY JOURNAL; VIRION;

EID: 0038297576     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(03)00117-6     Document Type: Article

References (55)

1. Adamson D.C., Wildemann B., Sasaki M., Glass J.D., McArthur J.C., Christov V.I., Dawson T.M., Dawson V.L. Immunologic no synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science. 274:1996;1917-1926.
2. Batchelor P.E., Liberatore G.T., Wong J.Y., Porritt M.J., Frerichs F., Donnan G.A., Howells D.W. Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J. Neurosci. 19:1999;1708-1716.
3. Bazan J., Bacon K., Hardiman G., Wang W., Soo K., Rossi D., Greaves D., Zlotnik A., Schall T. A new class of membrane-bound chemokine with a CX3C motif. Nature. 385:1997;640-644.
4. Biber K., Zuurman M.W., Dijkstra I.M., Boddeke H.W. Chemokines in the brain: neuroimmunology and beyond. Curr. Opin. Pharmacol. 2:2002;63-68.
5. Boehme S.A., Lio F.M., Maciejewski-Lenoir D., Bacon K.B., Conlon P.J. The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia. J. Immunol. 165:2000;397-403.
6. Brenneman D.E., Westbrook G.L., Fitzgerald S.P., Ennist D.L., Elkins K.L., Ruff M.R., Pert C.B. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature. 335:1988;639-642.
7. Cambien B., Pomeranz M., Schmid-Antomarchi H., Millet M.A., Breittmayer V., Rossi B., Schmid-Alliana A. Signal transduction pathways involved in soluble fractalkine-induced monocytic cell adhesion. Blood. 97:2001;2031-2037.
8. Carpenter C.C., Cooper D.A., Fischl M.A., Gatell J.M., Gazzard B.G., Hammer S.M., Hirsch M.S., Jacobsen D.M., Katzenstein D.A., Montaner J.S., Richman D.D., Saag M.S., Schechter M., Schooley R.T., Thompson M.A., Vella S., Yeni P.G., Volberding P.A. Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. Jama. 283:2000;381-390.
9. Chao C.C., Hu S., Sheng W.S., Tsang M., Peterson P.K. Tumor necrosis factor-α mediates the release of bioactive transforming growth factor β in murine microglial cell cultures. Clin. Immunol. Immunopathol. 77:1995;358-365.
10. Chapman G.A., Moores K., Harrison D., Campbell C.A., Stewart B.R., Strijbos P.J. Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage. J. Neurosci. (Online). 20:2000;RC87.
11. Cotter R., Williams C., Ryan L., Erichsen D., Lopez A., Peng H., Zheng J. Fractalkine (CX3CL1) and brain inflammation: implications for HIV-1-associated dementia. J. Neurovirol. 8:2002;585-598.
12. Deshmukh M., Vasilakos J., Deckwerth T.L. Genetic and metabolic status of NGF-deprived sympathetic neurons saved by an inhibitor of ICE family proteases. J. Cell. Biol. 135:1996;1341-1354.
13. Dichmann S., Herouy Y., Purlis D., Rheinen H., Gebicke-Harter P., Norgauer J. Fractalkine induces chemotaxis and actin polymerization in human dendritic cells. Inflamm. Res. 50:2001;529-533.
14. Elkabes S., DiCicco-Bloom E.M., Black I.B. Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function. J. Neurosci. 16:1996;2508-2521.
15. Everall I., Heaton R., Markotte T., Ellis R., Cutchan J., Atkinson J., Grant I., Mallory M., Masliah E. Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocortical disorder. HNRC Group. HIV Neurobehavioral Research Center. Brain Pathol. 9:1999;209-217.
16. Fong A.M., Erickson H.P., Zachariah J.P., Poon S., Schamberg N.J., Imai T., Patel D.D. Ultrastructure and function of the fractalkine mucin domain in CX(3)C chemokine domain presentation. J. Biol. Chem. 275:2000;3781-3786.
17. Foussat A., Coulomb-L'Hermine A., Gosling J., Krzysiek R., Durand-Gasselin I., Schall T., Balian A., Richard Y., Galanaud P., Emilie D. Fractalkine receptor expression by T lymphocyte subpopulations and in vivo production of fractalkine in human. Eur. J. Immunol. 30:2000;87-97.
18. Gabuzda D., Wang J., Gorry P. HIV-1-associated dementia. Ransohoff R.M., Suzuki K., Proudfoot A.E.I., Hickey W.F., Harrison J.K. Chemokines and the Nervous System. 2002;345-360 Elservier, Amsterdam.
19. Garaci E., Caroleo M.C., Aloe L., Aquaro S., Piacentini M., Costa N., Amendola A., Micera A., Calio R., Perno C.F., Levi-Montalcini R. Nerve growth factor is an autocrine factor essential for the survival of macrophages infected with HIV. Proc. Natl. Acad. Sci. U. S. A. 96:1999;14013-14018.
20. Gelbard H., Nottet H., Dzenko K., Jett M., Genis P., White R., Wang L., Choi Y.-B., Zhang D., Lipton S., Swindells S., Epstein L., Gendelman H. Platelet-activating factor: a candidate human immunodeficiency virus type-1 infection neurotoxin. J. Virol. 68:1994;4628-4635.
21. Gendelman H.E. The neuropathogenesis of HIV-1-dementia. Gendelman H.E., Lipton S.A., Epstein L.G., Swindells S. The Neurology of AIDS. 1997;1-10 Chapman & Hall, New York.
22. Gendelman H.E., Orenstein J.M., Martin M.A., Ferrua C., Mitra R., Phipps T., Wahl L.A., Lane H.C., Fauci A.S., Burke D.S. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J. Exp. Med. 167:1988;1428-1441.
23. Genis P., Jett M., Bernton E., Boyle T., Gelbard H., Dzenko K., Keane R., Resnick L., Mizrachi Y., Volsky D., Epstein L., Gendelman H. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J. Exp. Med. 176:1992;1703-1718.
24. Giulian D., Yu J., Xia L., Tom D., Li J., Lin S.N., Schwarz R., Noonan C. Study of receptor-mediated neurotoxins released by HIV-1 infected mononuclear phagocytes found in human brain. J. Neurosci. 16:1996;3139-3153.
25. Glass J.D., Wesselingh S.L., Selnes O.A., McArthur J.C. Clinical neuropathologic correlation in HIV-associated dementia. Neurology. 43:1993;2230-2237.
26. Harrison J.K., Jiang Y., Chen S., Xia Y., Maciejewski D., McNamara R.K., Streit W.J., Salafranca M.N., Adhikari S., Thompson D.A., Botti P., Bacon K.B., Feng L. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc. Natl. Acad. Sci. 95:1998;10896-10901.
27. Harrison J.K., Fong A.M., Swain P.A., Chen S., Yu Y.R., Salafranca M.N., Greenleaf W.B., Imai T., Patel D.D. Mutational analysis of the fractalkine chemokine domain: basic amino acid residues differentially contribute to CX3CR1 binding, signaling, and cell adhesion. J. Biol. Chem. 8:2001;8.
28. Heyes M.P., Brew B.B., Martin A., Price R.W., Salazar A., Sidtis J.J., Yergey J.A., Mouradian M.M., Sadler A.E., Keilp J., Rubinow R., Markey S.P. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann. Neurol. 29:1991;202-209.
29. Imai T., Hieshima K., Haskell C., Baba M., Nagira M., Nishimura M., Kakizaki M., Takagi S., Nomiyama H., Schall T.J., Yoshie O. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell. 91:1997;521-530.
30. Inngjerdingen M., Damaj B., Maghazachi A.A. Expression and regulation of chemokine receptors in human natural killer cells. Blood. 97:2001;367-375.
31. Jiang Z., Piggee C., Heyes M.P., Murphy C., Quearry B., Bauer M., Zheng J., Gendelman H.E., Markey S.P. Glutamate is a mediator of neurotoxicity in secretions of activated HIV- 1-infected macrophages. J. Neuroimmunol. 117:2001;97-107.
32. Kerschensteiner M., Gallmeier E., Behrens L., Leal V.V., Misgeld T., Klinkert W.E., Kolbeck R., Hoppe E., Oropeza-Wekerle R.L., Bartke I., Stadelmann C., Lassmann H., Wekerle H., Hohlfeld R. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J. Exp. Med. 189:1999;865-870.
33. Krebs F.C., Ross H., McAllister J., Wigdahl B. HIV-1-associated central nervous system dysfunction. Adv. Pharmacol. 49:2000;315-385.
34. Kutsch O., Oh J., Nath A., Benveniste E.N. Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes. J. Virol. 74:2000;9214-9221.
35. Lopez A., Bauer M.A., Erichsen D.A., Peng H., Gendelman L., Shibata A., Gendelman H.E., Zheng J. The regulation of neurotrophic factor activities following HIV-1 infection and immune activation of mononuclear phagocytes. Soc. Neurosci. Abs. 27:2001;. (San Diego).
36. Maciejewski-Lenoir D., Chen S., Feng L., Maki R., Bacon K.B. Characterization of fractalkine in rat brain cells: migratory and activation signals for CX3CR-1-expressing microglia. J. Immunol. 163:1999;1628-1635.
37. Marder K., Albert S., Dooneief G., Stern Y., Ramachandran G., Epstein L. Clinical confirmation of the american academy of neurology algorithm for HIV-1-associated cognitive/motor disorder. Neurology. 47:1996;1247-1253.
38. Masliah E., Ge N., Achim C.L., DeTeresa R., Wiley C.A. Patterns of neurodegeneration in HIV encephalitis. NeuroAIDS. 1:1996;161-173.
39. Masliah E., Heaton R.K., Marcotte T.D., Ellis R.J., Wiley C.A., Mallory M., Achim C.L., McCutchan A., Nelson J.A., Atkinson J.H., Grant I. Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. Ann. Neurol. 42:1997;963-972.
40. Meucci O., Fatatis A., Simen A.A., Miller R.J. Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc. Natl. Acad. Sci. U. S. A. 97:2000;8075-8080.
41. Miwa T., Furukawa S., Nakajima K., Furukawa Y., Kohsaka S. Lipopolysaccharide enhances synthesis of brain-derived neurotrophic factor in cultured rat microglia. J. Neurosci. Res. 50:1997;1023-1029.
42. Mollace V., Nottet H.S., Clayette P., Turco M.C., Muscoli C., Salvemini D., Perno C.F. Oxidative stress and neuroAIDS: triggers, modulators and novel antioxidants. Trends Neurosci. 24:2001;411-416.
43. Nath A., Geiger J. Neurobiological aspects of human immunodeficiency virus infection: neurotoxic mechanisms. Prog. Neurobiol. 54:1998;19-33.
44. Pereira C.F., Middel J., Jansen G., Verhoef J., Nottet H.S. Enhanced expression of fractalkine in HIV-1 associated dementia. J. Neuroimmunol. 115:2001;168-175.
45. Ransohoff R. Chemokines in neurological disease models: correlation between chemokine expression patterns and inflammatory pathology. J. Leukocyte Biol. 62:1997;645-652.
46. Ratner L., Haseltime W., Patarca R., Livak K.J., Starcich B., Josephs S.F., Doran E.R., Rafalski J.A., Whitehorn E.A., Baumeister K., Ivanoff L., Petteway S.R., Pearson M.L., Lautenberger J.A., Papas T.S., Ghrayeb J., Chang N.T., Gallo R.C., Wong-Staal F. Complete nucletide sequence of the AIDS virus, HTLV-III. Nature. 313:1985;277-284.
47. Rocamora N., Pascual M., Acsady L., Lecea L.D., Freund T.F. Expression of NGF and NT3 mRNAs hippocampal interneurons innervated by the GABAergic septohippocampal pathway. J. Neurosci. 16:1996;3991-4004.
48. Sacktor N., Lyles R.H., Skolasky R., Kleeberger C., Selnes O.A., Miller E.N., Becker J.T., Cohen B., McArthur J.C. HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology. 56:2001;257-260.
49. Tong N., Perry S.W., Zhang Q., James H.J., Guo H., Brooks A., Bal H., Kinnear S.A., Fine S., Epstein L.G., Dairaghi D., Schall T.J., Gendelman H.E., Dewhurst S., Sharer L.R., Gelbard H.A. Neuronal fractalkine expression in HIV-1 encephalitis: roles for macrophage recruitment and neuroprotection in the central nervous system. J. Immunol. 164:2000;1333-1339.
50. Wiley C.A., Masliah E., Morey M., Lemere C., Teresa R., Grafe M., Hansen L., Terry R. Neocortical damage during HIV infection. Ann. Neurol. 29:1991;651-657.
51. Wu D.T., Woodman S.E., Weiss J.M., McManus C.M., D'Aversa T.G., Hesselgesser J., Major E.O., Nath A., Berman J.W. Mechanisms of leukocyte trafficking into the CNS. J. Neurovirol. 6(Suppl. 1):2000;S82-S85.
52. Zheng J., Ghorpade A., Niemann D., Cotter R.L., Thylin M.R., Epstein L., Swartz J.M., Shepard R.B., Liu X., Nukuna A., Gendelman H.E. Lymphotropic virions affect chemokine receptor-mediated neural signaling and apoptosis: implications for human immunodeficiency virus type 1-associated dementia. J. Virol. 73:1999;8256-8267.
53. Zheng J., Thylin M., Ghorpade A., Xiong H., Persidsky Y., Cotter R., Niemann D., Che M., Zeng Y., Gelbard H., Shepard R., Swartz J., Gendelman H. Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia. J. Neuroimmunol. 98:1999;185-200.
54. Zheng J., Bauer M., Cotter R.L., Ryan L.A., Lopez A., Williams C., Ghorpade A., Gendelman H.E. Fractalkine mediated macrophage activation by neuronal injury: relevance for HIV-1 associated dementia. 30th Annual Meeting of Society for Neuroscience. vol. 26:2000;Society for Neuroscience, New Orleans.
55. Zujovic V., Benavides J., Vige X., Carter C., Taupin V. Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation. [In Process Citation] Glia. 29:2000;305-315.